1. Home
  2. PACS vs VERA Comparison

PACS vs VERA Comparison

Compare PACS & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PACS
  • VERA
  • Stock Information
  • Founded
  • PACS 2013
  • VERA 2016
  • Country
  • PACS United States
  • VERA United States
  • Employees
  • PACS N/A
  • VERA N/A
  • Industry
  • PACS
  • VERA Biotechnology: Pharmaceutical Preparations
  • Sector
  • PACS
  • VERA Health Care
  • Exchange
  • PACS Nasdaq
  • VERA Nasdaq
  • Market Cap
  • PACS 2.2B
  • VERA 2.4B
  • IPO Year
  • PACS 2024
  • VERA 2021
  • Fundamental
  • Price
  • PACS $12.80
  • VERA $28.58
  • Analyst Decision
  • PACS Strong Buy
  • VERA Buy
  • Analyst Count
  • PACS 9
  • VERA 8
  • Target Price
  • PACS $33.22
  • VERA $66.38
  • AVG Volume (30 Days)
  • PACS 571.6K
  • VERA 985.9K
  • Earning Date
  • PACS 03-04-2025
  • VERA 03-19-2025
  • Dividend Yield
  • PACS N/A
  • VERA N/A
  • EPS Growth
  • PACS 82.79
  • VERA N/A
  • EPS
  • PACS 0.68
  • VERA N/A
  • Revenue
  • PACS $3,558,953,000.00
  • VERA N/A
  • Revenue This Year
  • PACS $30.36
  • VERA N/A
  • Revenue Next Year
  • PACS $16.86
  • VERA N/A
  • P/E Ratio
  • PACS $19.37
  • VERA N/A
  • Revenue Growth
  • PACS 205.08
  • VERA N/A
  • 52 Week Low
  • PACS $12.54
  • VERA $25.99
  • 52 Week High
  • PACS $43.92
  • VERA $51.61
  • Technical
  • Relative Strength Index (RSI)
  • PACS N/A
  • VERA 29.57
  • Support Level
  • PACS N/A
  • VERA $25.99
  • Resistance Level
  • PACS N/A
  • VERA $34.79
  • Average True Range (ATR)
  • PACS 0.00
  • VERA 2.15
  • MACD
  • PACS 0.00
  • VERA -0.56
  • Stochastic Oscillator
  • PACS 0.00
  • VERA 20.05

About PACS PACS Group Inc. Common Stock

PACS Group Inc is a post-acute healthcare company primarily focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities Its is a nursing providers in the United States based on number of facilities, with over 200 post-acute care facilities across nine states serving over 20,000 patients daily. It also provide senior care, assisted living, and independent living options in some of communities.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: